This is a long-term, OLE study of levoketoconazole in subjects with endogenous CS who have completed one or both parent studies or otherwise potentially qualify for this study, as defined in the eligibility criteria.
This is a long-term, open-label extension study of levoketoconazole in subjects with endogenous Cushing's Syndrome.